can tirzepatide cause inflammation Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology The promise of tirzepatide: A

Much like statins reshaped cardiovascular medicine, I suspect well look back on GLP-1s as the beginning of a new era in preventive and cognitive medicine. As a result, their reach has widened far beyond the diabetic and obese populations to a much broader segment of adults seeking sustainable metabolic and longevity health including early adopters experimenting with microdosing protocols for appetite control and energy regulation

Such a model fits well with the finding by Faucheux et al

The face looks tired in a new way

Individuals experiencing hormonal imbalances that affect their sleep and overall well-being can benefit from DSIPs role in regulating the endocrine system